MENU

December 14, 2021

I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project

Global CDMO utilizes Seattle facility’s mammalian biologics expertise to support late-stage clinical trials for leading international biopharma organization Seattle, Dec. 13, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a

Read More ➜

Recent News

ADVERTISMENT